Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

MyCloudz Completes Acquisition Of Gridiron BioNutrients™ to enter the CBD Wellness Industry

Gridiron BioNutrients
Posted on: 31 Oct 17

SPOKANE, Wash., Oct. 31, 2017 /PRNewswire/ -- MyCloudz, Inc. (OTC: MYYZ) announces it has completed the acquisition of Gridiron BioNutrients™ in a share-for-share transaction.

The Company is changing its operating name to Gridiron BioNutrients™ and will provide wide range of innovative CBD wellness products to its customers.

Under the guidance of its founder Darren Long, a former NFL and USFL Tight End as well as a 3x College Football All American, the Company will focus its marketing on producing innovative nutritional products infused with the highest quality CBD available.  Darren is on the frontline formulating natural products that promote healing and wellness. He is currently working with several NFL alumni whom have been diagnosed with Chronic Traumatic Encephalopathy "CTE" (brain concussions) as well as those suffering from debilitating diseases. Darren's passion for individual health and wellness is based upon his own professional and personal experiences.

https://gridironbionutrients.com/team/darren-long/

Cannabidiol—CBD—is a cannabis compound that may have significant medical benefits, but does not make people feel "stoned".  CBD is non-psychoactive, which makes it an appealing option for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and other conditions without disconcerting feelings of lethargy or dysphoria. 

Scientific and clinical research, much of it sponsored by the US government, underscores CBD's potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. 

CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere. Further evidence suggests that CBD is safe even at high doses.

According to Forbes the cannabidiol (CBD) market is estimated to grow 700% by 2020. A new report by market intelligence firm Hemp Business Journal also projects that the CBD market will grow to $2.1 billion by 2020, an astronomical jump in value compared to last year's CBD market of $202 million.

About Gridiron BioNutrients™

Gridiron's current CBD products include Gridiron MVP™ water, Gridiron MVP™ concentrate, Gridiron Premium Hemp Salve, Gridiron Premium Hemp Oil and Gridiron Premium Hemp Oil Capsules.  The Company plans to roll-out additional products over the next twelve months.  Gridiron's unique flagship product, Gridiron MVP™ water and concentrate is an innovative formulation that delivers Humic and Fulvic minerals, Probiotics, Electrolytes, 77+ trace minerals and Premium Nano CBD with a pH of 10. 

Website: https://gridironbionutrients.com

Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.   Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Stony Hill Corp. (the "Company") or its management, identify forward-looking statements.  These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission.  Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE:  These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program.  All information presented here is not meant as a substitute for information from health care practitioners.   

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 31/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.